Glenmark Life Sciences inks CDMO supply deal with a Japanese pharma innovator
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Evinova will operate as a separate health-tech business within AstraZeneca
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Lokavant provides clinical trial intelligence
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Subscribe To Our Newsletter & Stay Updated